Navigation Links
Quigley Corporation Announces Final Results of Quigley Pharma's Phase IIb Study
Date:7/22/2009

iminary analysis of the lack of adequate primary and secondary end point data indicates that the results may have been attributed to fewer then expected evaluable patients due to a shortage of drug and a high number of patients terminated early due to a lack of compliance with application and usage protocols.

"We have recently hired an independent consultant to conduct a thorough review of the entire research and development portfolio of potential products in the Quigley Pharma pipeline," said Ted Karkus, CEO. "We will wait for this review to be completed before determining the next steps in the development of QR-333 and other formulations."

All required end of study regulatory and reporting documentation and procedures will be completed. Consistent with previous announcements and pending the full review of the product portfolio, the Company will continue to consider licensing, partnering or collaborative relationship opportunities to further the development and potential commercialization of the QR-333 candidate and other formulations.

The ADA estimates that neuropathy occurs in up to 60-70% of diabetics, and an estimated 5 million Americans are affected by diabetic peripheral neuropathic pain. The World Health Organization estimates that more than 171 million people have diabetes worldwide, a figure that is expected to rise to 366 million by 2030.

About the study:

Methodology:

This was a double-blind, randomized, parallel-group, placebo controlled study conducted at 22 sites with 1 to 27 patients randomized per site. Patients between the ages of 18 and 70 years with a diagnosis of diabetes and symptoms of peripheral neuropathy were eligible for enrollment into the study. Eligible patients were randomized to 1 of 2 groups each applying study cream topically to the feet three times daily (tid) with placebo or QR-333 for
'/>"/>

SOURCE Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ted Karkus Named CEO of The Quigley Corporation; Robert V. Cuddihy, Jr. Named Chief Operating Officer
2. Dr. Richard Rosenbloom Resumes Services To The Quigley Corporations Pharma Subsidiary
3. Ted Karkus Appointed Interim Chief Executive Officer Of The Quigley Corporation
4. Ted Karkus and Karkus Slate of Directors Prevail in Federal Court, Seated as Directors of The Quigley Corporation; Ted Karkus Elected Chairman of the Board
5. The Quigley Corporation Announces Final Voting Results for 2009 Annual Meeting of Shareholders; Judge Orders Incumbent Board to Remain In Place Until Further Hearing; Final Outcome of Director Election Remains Uncertain
6. Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation
7. Karkus Nominees Caution Quigley Shareholders Not to be Fooled by the Companys Latest Announcement
8. The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
9. Judge Rejects Quigleys Claims - Karkus Director Candidates Prevail in Federal Court
10. Quigley Corporation Receives Support from Leading Independent Proxy Advisory Firms; RiskMetrics and Glass Lewis Reject Dissident Stockholder Ted Karkus, Citing Failure to Provide Detailed Business Plan
11. The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus Solicitation Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 For more than ... cold storage consumers with dynamic, specialized humidification ... customer satisfaction. Offering 50-70% less energy requirements than ... This process is completed through a non-chemical procedure ... also provide a 4.2 Micron droplet. The size ...
(Date:7/22/2014)... Texas (PRWEB) July 22, 2014 For ... Advocate Foundation (PAF) have been working in tandem to ... insurance options, facilitate access to care, and help survivors ... 2014, the two foundations expanded their partnership to include ... by cancer deal with the other practical, emotional, and ...
(Date:7/22/2014)... Get Real Health announced today a ... (IDF) to provide their patient community with a new ... electronically track their symptoms, medications and other health-related information—enabling ... allow those patients and families who want to ... shared with the U.S. Immunodeficiency Network (USIDNET) registry, ...
(Date:7/22/2014)... Atreo Services will be presenting its full ... and accessories in booth #1423 at the American Society ... in Chicago, Ill., Aug. 3-6. , Atreo will display ... as well as its selection of liners and inserts ... In addition, representatives will be available to talk ...
(Date:7/22/2014)... Altec Products, Inc. , a leader ... their Gold Sponsorship of Sage Summit 2014 ... and Casino in Las Vegas, Nevada. The largest educational ... in taking advantage of the many opportunities to network ... and educate themselves on the latest enterprise resource planning ...
Breaking Medicine News(10 mins):Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 2Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 3Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3
... -- Women may be less likely to develop premenstrual syndrome ... B vitamins, a new study suggests. Women who ... reduced their risk of PMS, the data suggested. Thiamine ... and researchers said eating two to three servings of thiamine-rich ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, March 14 ... is, a pediatrician or nurse they see regularly who offers comprehensive ... needs met, new research finds. Yet it,s the sickest children ... require the most care -- who are less likely to get ...
... for healthier humans around the globe are making headway ... diarrheal illness, according to research from the Frederick S. ... Denver,s (DU) Josef Korbel School of International Studies. ... a series of five volumes that focus on human ...
... 14, 2011The first human studies of an oral drug regimen ... near 50% reduction in HIV incidence, but a number of ... be implemented on a large scale, according to an article ... journal published by Mary Ann Liebert, Inc. ( www.liebertpub.com ). ...
... Education recently received a five year, $3.7 million grant ... to fund a project aimed at preventing obesity among ... mothers simple yet authoritative strategies to promote appropriate food ... was awarded to Jenifer Orlet Fisher, associate professor of ...
... National Institute of Allergy and Infectious Diseases (NIAID), part ... the O157:H7 strain of Escherichia coli causes ... The bacterium secretes a protein called NleH1 that directs ... responses. This process not only helps the bacterium evade ...
Cached Medicine News:Health News:Diets Rich in Vitamin B May Help Prevent PMS, Study Finds 2Health News:'Medical Homes' Help Kids Get Comprehensive Care 2Health News:'Medical Homes' Help Kids Get Comprehensive Care 3Health News:DU researchers find that headway being made fighting communicable diseases globally 2Health News:DU researchers find that headway being made fighting communicable diseases globally 3Health News:Early success of anti-HIV preventive oral drug regimen is promising, but questions remain 2Health News:Temple receives $3.7 million to study parenting styles' effect on childhood obesity 2
(Date:7/22/2014)... , July 22, 2014  According to the American ... children spend on digital devices. An AOA survey reports ... 10 and 17 estimate they use an electronic device ... separate AOA survey of parents revealed that only 40 ... device for that same amount of time. Eye doctors ...
(Date:7/22/2014)... , July 22, 2014 Quantum Materials Corporation (OTCQB:QTMM) ... Mr. John Heaton to the Board of Directors. QMC ... Ghassan Jabbour , QMC Chief Science Officer and Board of ... Wong of Rice University and Mr. Tomio Gotoh , ... . " Quantum Materials welcomes two new ...
(Date:7/21/2014)... -- Champions Oncology (OTC: CSBR), a company engaged in the ... the development and use of oncology drugs, today announced ... the fourth quarter and fiscal year ended April 30, ... The company will host a conference call ... EDT (1:30 p.m. PDT). To participate in the call, ...
Breaking Medicine Technology:Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4
... May 5, 2011 IRIDEX Corporation (Nasdaq: IRIX ) ... sales and improved financial results for the first quarter ended April ... $0.06 per diluted share, up from $0.5 million or $0.05 per ... ophthalmology sales grew 10%. Total sales increased to $11.2 million ...
... Inc. (Nasdaq: BIOD ) today reported financial results for ... Fiscal Year 2011 Financial Results Biodel reported a net ... million, or $0.21 per share, compared to a net loss of ... the prior year. Research and development expenses were ...
Cached Medicine Technology:IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 2IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 3IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 4IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 5Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 2Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 3Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 4Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 5Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 6
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: